Medicare Part D Incurs Substantial Savings with Generics, CBO Says



Dispensing generic drugs rather than their brand-name counterparts reduced prescription drug costs in the Medicare Part D by $33 billion in one year, a Congressional Budget Office report says.


Name:
E-mail:
Website:  
Please enter your comment below:
Please enter the text below:

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.